2 completed, 1 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow Epclusa: new trials by email Literature Review of Epclusa trials Research Report on Epclusa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Micro-elimination of Hepatitis C Virus Infection in Uremics Epclusa - Hepatitis C | Phase 3 | Unknown | Kaohsiung Medical University Chung-Ho Memorial Hospital | 135 | 2019-05-13 | 2020-07-10 |
| Utilization of Hepatitis C Positive Kidneys in Negative Recipients Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET] - Kidney Transplant, Hepatitis C | Phase 2 / Phase 3 | Completed | Ohio State University | 54 | 2019-03-22 | 2023-09-13 |
| Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia Harvoni, Epclusa - Hepatitis C, Cryoglobulinemia | Phase 2 / Phase 3 | Completed | Icahn School of Medicine at Mount Sinai | 10 | 2016-02-01 | 2020-12-17 |
Hepatitis C (3) · Cryoglobulinemia (1)
Icahn School of Medicine at Mount Sinai (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · Ohio State University (1)
United States (2) · Taiwan (1)
Ming-Lung Yu, MD.,PhD. (1) · Peter Gorevic, MD (1) · Reem Daloul, MD (1)